Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
New Approaches to Neuroblastoma Therapy Consortium Identifier:
First received: November 24, 2009
Last updated: December 11, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2015
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)